142 related articles for article (PubMed ID: 18374395)
1. Use of a temporary prostatic stent after transurethral microwave thermotherapy reduced voiding symptoms and bother without exacerbating irritative symptoms.
Dineen MK; Shore ND; Lumerman JH; Saslawsky MJ; Corica AP
Urology; 2008 May; 71(5):873-7. PubMed ID: 18374395
[TBL] [Abstract][Full Text] [Related]
2. A temporary intraurethral prostatic stent relieves prostatic obstruction following transurethral microwave thermotherapy.
Shore ND; Dineen MK; Saslawsky MJ; Lumerman JH; Corica AP
J Urol; 2007 Mar; 177(3):1040-6. PubMed ID: 17296408
[TBL] [Abstract][Full Text] [Related]
3. Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
Kaplan SA; Roehrborn CG; Chancellor M; Carlsson M; Bavendam T; Guan Z
BJU Int; 2008 Nov; 102(9):1133-9. PubMed ID: 18510659
[TBL] [Abstract][Full Text] [Related]
4. [Prevention of temporary prostatic obstruction after high-energy microwave thermothery by placement of prostatic bridge catheter].
Djavan B; Seitz C; Fakhari M; Ghawidel K; Marberger M
Prog Urol; 1999 Apr; 9(2):261-70. PubMed ID: 10370950
[TBL] [Abstract][Full Text] [Related]
5. Effects of tamsulosin on lower urinary tract symptoms due to double-J stent: a prospective study.
Wang CJ; Huang SW; Chang CH
Urol Int; 2009; 83(1):66-9. PubMed ID: 19641362
[TBL] [Abstract][Full Text] [Related]
6. Five-year follow-up of feedback microwave thermotherapy versus TURP for clinical BPH: a prospective randomized multicenter study.
Mattiasson A; Wagrell L; Schelin S; Nordling J; Richthoff J; Magnusson B; Schain M; Larson T; Boyle E; Duelund-Jacobsen J; Kroyer K; Ageheim H
Urology; 2007 Jan; 69(1):91-6; discussion 96-7. PubMed ID: 17270624
[TBL] [Abstract][Full Text] [Related]
7. [Changes of urinary symptoms after transurethral resection of the prostate and its correlation with clinical parameters].
Zhao Z; Wang G; Na YQ
Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(14):957-9. PubMed ID: 17961379
[TBL] [Abstract][Full Text] [Related]
8. Relationship between lower urinary tract symptoms and objective measures of benign prostatic hyperplasia: a Chinese survey.
Wang JY; Liu M; Zhang YG; Zeng P; Ding Q; Huang J; He DL; Song B; Kong CZ; Pang J
Chin Med J (Engl); 2008 Oct; 121(20):2042-5. PubMed ID: 19080272
[TBL] [Abstract][Full Text] [Related]
9. Adverse effect of radical prostatectomy on nocturia and voiding frequency symptoms.
Namiki S; Saito S; Ishidoya S; Tochigi T; Ioritani N; Yoshimura K; Terai A; Arai Y
Urology; 2005 Jul; 66(1):147-51. PubMed ID: 15992905
[TBL] [Abstract][Full Text] [Related]
10. [Role of prostatic stents and transurethral microwave thermotherapy in the treatment of voiding disorders related to benign prostatic hyperplasia (CTMH-AFU forum 2005)].
; Saussine C; Devonec M; Haillot O; Fourmarier M; Desgrandchamps F; Ballereau C; Azzouzi AR; Lukacs B; de la Taille A
Prog Urol; 2006 Nov; 16(5):533-6. PubMed ID: 17175945
[TBL] [Abstract][Full Text] [Related]
11. [The role of the IPSS (International Prostate Symptoms Score) to evaluate the frequency of disability induced by each of the 7 symptoms. (CTMH-AFU study)].
de la Taille A; Desgrandchamps F; Haillot O; Saussine C; Lukacs B; Marc F;
Prog Urol; 2006 Nov; 16(5):568-71. PubMed ID: 17175953
[TBL] [Abstract][Full Text] [Related]
12. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study.
Roehrborn CG; McVary KT; Elion-Mboussa A; Viktrup L
J Urol; 2008 Oct; 180(4):1228-34. PubMed ID: 18722631
[TBL] [Abstract][Full Text] [Related]
13. [Use of alpha1-adrenergic blockaders in treating voiding disorders after transurethral resection of the prostate].
Martov AG; Gushchin BL; Oshchepkov VN; Ergakov DV
Urologiia; 2002; (5 Suppl):23-37. PubMed ID: 12518670
[TBL] [Abstract][Full Text] [Related]
14. Bothersome urinary symptoms and disease-specific quality of life in patients with benign prostatic obstruction.
Marklund-Bau H; Edéll-Gustafsson U; Spångberg A
Scand J Urol Nephrol; 2007; 41(1):32-41. PubMed ID: 17366100
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and predictive value of voiding diary data versus prostate volume, maximal free urinary flow rate, and Abrams-Griffiths number in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
van Venrooij GE; van Melick HH; Eckhardt MD; Boon TA
Urology; 2008 Mar; 71(3):469-74. PubMed ID: 18342189
[TBL] [Abstract][Full Text] [Related]
16. A Spanner in the works: the use of a new temporary urethral stent to relieve bladder outflow obstruction after prostate brachytherapy.
Henderson A; Laing RW; Langley SE
Brachytherapy; 2002; 1(4):211-8. PubMed ID: 15062169
[TBL] [Abstract][Full Text] [Related]
17. Ureteral stents: morbidity and impact on quality of life.
Leibovici D; Cooper A; Lindner A; Ostrowsky R; Kleinmann J; Velikanov S; Cipele H; Goren E; Siegel YI
Isr Med Assoc J; 2005 Aug; 7(8):491-4. PubMed ID: 16106772
[TBL] [Abstract][Full Text] [Related]
18. Long-term results of three different minimally invasive therapies for lower urinary tract symptoms due to benign prostatic hyperplasia: comparison at a single institute.
Ohigashi T; Nakamura K; Nakashima J; Baba S; Murai M
Int J Urol; 2007 Apr; 14(4):326-30. PubMed ID: 17470164
[TBL] [Abstract][Full Text] [Related]
19. Effect of dutasteride on the symptoms of benign prostatic hyperplasia, and patient quality of life and discomfort, in clinical practice.
Desgrandchamps F; Droupy S; Irani J; Saussine C; Comenducci A
BJU Int; 2006 Jul; 98(1):83-8. PubMed ID: 16831149
[TBL] [Abstract][Full Text] [Related]
20. Predictability of irritative voiding symptoms following photoselective laser vaporization of the prostate.
Matoka DJ; Averch TD
Can J Urol; 2007 Oct; 14(5):3710-4. PubMed ID: 17949529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
